Michael Panzara
2017
In 2017, Michael Panzara earned a total compensation of $1.1M as Chief Medical Officer at Wave Life Sciences Ltd., a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,800 |
|---|---|
| Option Awards | $255,614 |
| Salary | $417,800 |
| Stock Awards | $200,445 |
| Other | $9,342 |
| Total | $1,067,001 |
Panzara received $417.8K in salary, accounting for 39% of the total pay in 2017.
Panzara also received $183.8K in non-equity incentive plan, $255.6K in option awards, $200.4K in stock awards and $9.3K in other compensation.
Rankings
In 2017, Michael Panzara's compensation ranked 8,680th out of 14,666 executives tracked by ExecPay. In other words, Panzara earned more than 40.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,680 out of 14,666 | 41st |
Division Manufacturing | 3,303 out of 5,770 | 43rd |
Major group Chemicals And Allied Products | 1,116 out of 2,074 | 46th |
Industry group Drugs | 887 out of 1,730 | 49th |
Industry Pharmaceutical Preparations | 694 out of 1,329 | 48th |
Source: SEC filing on June 26, 2019.
Panzara's colleagues
We found four more compensation records of executives who worked with Michael Panzara at Wave Life Sciences Ltd. in 2017.
2017
Paul Bolno
Wave Life Sciences Ltd.
Chief Executive Officer
2017
Chandra Vargeese
Wave Life Sciences Ltd.
Senior Vice President, Drug Discovery
2017
Christopher Francis
Wave Life Sciences Ltd.
Senior Vice President, Corporate Development, Head of Emerging Areas
2017
Keith Regnante
Wave Life Sciences Ltd.